Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China · Delayed Price · Currency is CNY 27.30
+0.46 (1.71%)
At close: Jun 12, 2026
SHE:301246 Market Cap
SHE:301246 has a market cap or net worth of 10.83 billion as of June 12, 2026. Its market cap has increased by 102.22% in one year.
Market Cap
10.83B
Enterprise Value
9.84B
Revenue
2.21B
Ranking
n/a
PE Ratio
42.58
Stock Price
27.30
Market Cap Chart
Since March 20, 2023, SHE:301246's market cap has decreased from 16.78B to 10.83B, a decrease of -35.44%. That is a compound annual growth rate of -12.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 10.83B | 9.20% |
| Dec 31, 2025 | 9.92B | 84.22% |
| Dec 31, 2024 | 5.39B | -48.18% |
| Dec 29, 2023 | 10.39B | -38.07% |
| Mar 20, 2023 | 16.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shyndec Pharmaceutical | 11.67B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.47B |
| Zhejiang Medicine | 11.28B |
| Zhejiang Hisun Pharmaceutical | 11.19B |
| Zhejiang Jiuzhou Pharmaceutical | 11.04B |
| Shenzhen Chipscreen Biosciences | 11.02B |
| Zhejiang CONBA Pharmaceutical | 10.48B |
| Yantai Dongcheng Pharmaceutical Group | 10.30B |